Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88267134 |
LAW OFFICE ASSIGNED |
LAW OFFICE 128 |
MARK SECTION |
MARK |
MYPDZYME (see, http://uspto.report/TM/88267134/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
MYPDZYME |
OWNER SECTION (current) |
NAME |
Genzyme Corporation |
MAILING ADDRESS |
50 Binney Street |
CITY |
Cambridge |
STATE |
Massachusetts |
ZIP/POSTAL CODE |
02142 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
Genzyme Corporation |
MAILING ADDRESS |
50 Binney Street |
CITY |
Cambridge |
STATE |
Massachusetts |
ZIP/POSTAL CODE |
02142 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
Karen Lim |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
klim-docket@fzlz.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
klim-docket@fzlz.com |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Karen Lim |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
klim-docket@fzlz.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
GENZ 1901264 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system;
pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations
for the prevention and treatment of infectious diseases, namely, viral and bacterial infections |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
07/09/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/aude thrierr/ |
SIGNATORY'S NAME |
THRIERR Aude |
SIGNATORY'S POSITION |
Authorized Signatory pursuant to a Power of Attorney |
DATE SIGNED |
05/13/2020 |
FILING INFORMATION |
SUBMIT DATE |
Wed May 13 14:17:57 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XXX.XX-2
0200513141757693222-88267
134-710d7ee33ff31c314bb9a
5cd63570547f4e4dd3c1d6b7d
ff68071fac324fe6c1-DA-175
61865-2020050815380799612
1 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: MYPDZYME (see, http://uspto.report/TM/88267134/mark.png)
SERIAL NUMBER: 88267134
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Genzyme Corporation, having an address of
50 Binney Street
Cambridge, Massachusetts 02142
United States
Proposed: Genzyme Corporation, having an address of
50 Binney Street
Cambridge, Massachusetts 02142
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 07/09/2019.
For International Class 005:
Current identification: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the
treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of
infectious diseases, namely, viral and bacterial infections
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
Correspondence Information (current):
Karen Lim
PRIMARY EMAIL FOR CORRESPONDENCE: klim-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): klim-docket@fzlz.com
Correspondence Information (proposed):
Karen Lim
PRIMARY EMAIL FOR CORRESPONDENCE: klim-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /aude thrierr/ Date Signed: 05/13/2020
Signatory's Name: THRIERR Aude
Signatory's Position: Authorized Signatory pursuant to a Power of Attorney
RAM Sale Number: 88267134
RAM Accounting Date: 05/13/2020
Serial Number: 88267134
Internet Transmission Date: Wed May 13 14:17:57 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XX-2020051314175769
3222-88267134-710d7ee33ff31c314bb9a5cd63
570547f4e4dd3c1d6b7dff68071fac324fe6c1-D
A-17561865-20200508153807996121